AN2 Therapeutics, Inc. (ANTX)
NASDAQ: ANTX · Real-Time Price · USD
3.820
-0.350 (-8.39%)
At close: Jun 5, 2026, 4:00 PM EDT
3.750
-0.070 (-1.83%)
After-hours: Jun 5, 2026, 4:27 PM EDT
AN2 Therapeutics Market Cap
AN2 Therapeutics has a market cap or net worth of $137.5 million as of June 5, 2026. Its market cap has increased by 289.47% in one year.
Market Cap
137.50M
Enterprise Value
52.21M
1-Year Change
289.47%
Ranking
Category
Stock Price
$3.82
Market Cap Chart
Since the IPO on March 25, 2022, AN2 Therapeutics's market cap has decreased from $281.10M to $137.50M, a decrease of -51.08%. That is a compound annual growth rate of -15.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 137.50M | 340.17% |
| Dec 31, 2025 | 31.24M | -24.24% |
| Dec 31, 2024 | 41.23M | -93.23% |
| Dec 29, 2023 | 609.40M | 229.57% |
| Dec 30, 2022 | 184.91M | -34.22% |
| Mar 25, 2022 | 281.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ProQR Therapeutics | 161.20M |
| Korro Bio | 160.81M |
| Galectin Therapeutics | 156.74M |
| Oramed Pharmaceuticals | 155.93M |
| Jyong Biotech | 155.89M |
| Corbus Pharmaceuticals Holdings | 148.41M |
| NRx Pharmaceuticals | 146.59M |
| Connect Biopharma Holdings | 144.82M |